AU2747397A - Hiv protease inhibitors useful for the treatment of aids - Google Patents

Hiv protease inhibitors useful for the treatment of aids

Info

Publication number
AU2747397A
AU2747397A AU27473/97A AU2747397A AU2747397A AU 2747397 A AU2747397 A AU 2747397A AU 27473/97 A AU27473/97 A AU 27473/97A AU 2747397 A AU2747397 A AU 2747397A AU 2747397 A AU2747397 A AU 2747397A
Authority
AU
Australia
Prior art keywords
aids
treatment
protease inhibitors
hiv protease
inhibitors useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU27473/97A
Other versions
AU712120B2 (en
Inventor
Craig A Coburn
Mark E. Fraley
M Katharine Holloway
Randall W. Hungate
Kristine Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613487.9A external-priority patent/GB9613487D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2747397A publication Critical patent/AU2747397A/en
Application granted granted Critical
Publication of AU712120B2 publication Critical patent/AU712120B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU27473/97A 1996-05-02 1997-04-29 HIV protease inhibitors useful for the treatment of AIDS Ceased AU712120B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1669596P 1996-05-02 1996-05-02
US60/016695 1996-05-02
GBGB9613487.9A GB9613487D0 (en) 1996-06-27 1996-06-27 HIV protease inhibitors useful for the treatment of aids
GB9613487 1996-06-27
PCT/US1997/007131 WO1997040833A1 (en) 1996-05-02 1997-04-29 Hiv protease inhibitors useful for the treatment of aids

Publications (2)

Publication Number Publication Date
AU2747397A true AU2747397A (en) 1997-11-19
AU712120B2 AU712120B2 (en) 1999-10-28

Family

ID=26309579

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27473/97A Ceased AU712120B2 (en) 1996-05-02 1997-04-29 HIV protease inhibitors useful for the treatment of AIDS

Country Status (5)

Country Link
EP (1) EP0914125A4 (en)
JP (1) JP2000509392A (en)
AU (1) AU712120B2 (en)
CA (1) CA2252915A1 (en)
WO (1) WO1997040833A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4626896B2 (en) 1998-02-13 2011-02-09 ダイセル化学工業株式会社 Acylating agent, acylation method using the same, and adamantane derivative
ZA99981B (en) 1998-02-17 2000-08-08 Du Pont Pharm Co Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.
MXPA00012842A (en) * 1998-06-24 2004-06-22 Univ Emory Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504104A (en) * 1993-11-19 1996-04-02 Warner-Lambert Company Tricyclic pyrone derivatives as protease inhibitors and antiviral agents
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
US5480887A (en) * 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors

Also Published As

Publication number Publication date
AU712120B2 (en) 1999-10-28
CA2252915A1 (en) 1997-11-06
WO1997040833A1 (en) 1997-11-06
JP2000509392A (en) 2000-07-25
EP0914125A1 (en) 1999-05-12
EP0914125A4 (en) 2000-04-05

Similar Documents

Publication Publication Date Title
HU9503170D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU6822990A (en) Hiv protease inhibitors useful for the treatment of aids
AU4019289A (en) Hiv protease inhibitors useful for the treatment of aids
EP0604182A3 (en) Inhibitors of HIV protease useful for the treatment of Aids.
AU1954392A (en) Inhibitors of hiv protease useful for the treatment of aids
AU3107795A (en) Inhibitors of the benzamidine type
AU1795697A (en) Serine protease inhibitors
AU1877597A (en) Serine protease inhibitors
AU4135493A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU5252993A (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU1408300A (en) Hiv infection inhibitors
AU1556497A (en) Agents for the treatment and prevention of aids
ZA925023B (en) Inhibitors of HIV protease useful for the treatment of AIDS
AU1697197A (en) Immunoconjugate for the treatment of aids
AU2277597A (en) New inhibitors of sh2-mediated processes
AUPM982594A0 (en) HIV protease inhibitors
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
AU4672996A (en) Serine protease inhibitors
AU6828894A (en) Hiv protease inhibitors
EP0912170A4 (en) Hiv protease inhibitors useful for the treatment of aids
AU2747397A (en) Hiv protease inhibitors useful for the treatment of aids
AU3146997A (en) Pediatric formulation for hiv protease inhibitors
AU6271098A (en) Hiv integrase inhibitors
AU2001286489A1 (en) Process for the purification of iosoctane and/or diisobutylene
GB9508300D0 (en) HIV protease inhibtors for the treatment of aids